A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).
Clinical trial NCT02462759 · TERMINATED
Trial details
- NCT number
- NCT02462759
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-19
- Primary completion
- 2018-09-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.